Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US10137192B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2018 |
| Grant date | Nov 27, 2018 |
| Priority date | — |
| Expiry date | Apr 8, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.